Cetera Advisor Networks’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$1.36M Sell
47,347
-5,378
-10% -$162K 0.01% 1257
2023
Q4
$1.73M Buy
52,725
+3,202
+6% +$87.1K 0.01% 1038
2023
Q3
$1.38M Buy
49,523
+918
+2% +$30K 0.01% 1082
2023
Q2
$1.66M Sell
48,605
-45,922
-49% -$1.44M 0.01% 951
2023
Q1
$2.84M Buy
94,527
+98
+0.1% +$3.04K 0.02% 714
2022
Q4
$2.67M Sell
94,429
-4,195
-4% -$133K 0.02% 699
2022
Q3
$3.24M Buy
98,624
+6,506
+7% +$239K 0.04% 432
2022
Q2
$2.9M Buy
92,118
+8,916
+11% +$312K 0.04% 465
2022
Q1
$3.82M Sell
83,202
-9,067
-10% -$432K 0.05% 398
2021
Q4
$5.65M Sell
92,269
-69,993
-43% -$4.84M 0.07% 276
2021
Q3
$12.1M Buy
162,262
+5,302
+3% +$445K 0.16% 139
2021
Q2
$14.5M Buy
156,960
+9,740
+7% +$828K 0.2% 120
2021
Q1
$13.1M Sell
147,220
-29,452
-17% -$2.92M 0.28% 91
2020
Q4
$16.5M Sell
176,672
-56,436
-24% -$4.5M 0.38% 53
2020
Q3
$14.9M Buy
233,108
+65,729
+39% +$3.85M 0.39% 52
2020
Q2
$8.73M Sell
167,379
-14,331
-8% -$615K 0.23% 98
2020
Q1
$5.68M Buy
181,710
+3,401
+2% +$114K 0.19% 119
2019
Q4
$5.98M Buy
178,309
+48,706
+38% +$1.55M 0.16% 127
2019
Q3
$3.83M Sell
129,603
-4,122
-3% -$134K 0.12% 176
2019
Q2
$4.6M Buy
133,725
+725
+0.5% +$23.2K 0.14% 147
2019
Q1
$4.38M Buy
133,000
+82,569
+164% +$2.44M 0.14% 142
2018
Q4
$1.21M Buy
50,431
+40,719
+419% +$1.15M 0.05% 325
2018
Q3
$326K Sell
9,712
-40
-0.4% -$1.27K 0.01% 812
2018
Q2
$285K Sell
9,752
-540
-5% -$15K 0.01% 660
2018
Q1
$264K Buy
+10,292
New +$279K 0.01% 709

Other funds holding ARKG

Cetera Advisor Networks's ARKG Position: Q1 2024 in Review

Cetera Advisor Networks reduced its ARK Genomic Revolution ETF (ARKG) stake by 10% in Q1 2024, selling an estimated $162K and leaving 47,347 shares worth $1.36M. The position accounts for 0.01% of the portfolio, ranked #1257.

Cetera Advisor Networks first reported a position in ARKG in Q1 2018 and has held it in 25 quarters since. The position peaked at $16.5M in Q4 2020. 286 funds tracked by Wall St. Rank hold ARKG as of Q1 2024.

  • Cetera Advisor Networks held 47,347 shares of ARK Genomic Revolution ETF worth $1.36M as of Q1 2024.
  • Cetera Advisor Networks sold 5,378 ARK Genomic Revolution ETF shares in Q1 2024, an estimated $162K.
  • ARK Genomic Revolution ETF made up 0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #1257 holding.
  • Cetera Advisor Networks first reported a position in ARK Genomic Revolution ETF in Q1 2018 and has held it in 25 quarters since.
  • Cetera Advisor Networks's ARK Genomic Revolution ETF position peaked at $16.5M in Q4 2020.
  • 286 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.